drugset

drugset / Trial / NCT04690283

Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial

NCT04690283 ↗

Phase 3 Unknown 360 enrolled Nanjing NingQi Medicine Science and Technology Co., Ltd. Fudan University · collab Jiangsu Cancer Institute & Hospital · collab Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine · collab The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · collab The First Affiliated Hospital with Nanjing Medical University · collab

RandomizedParallel-groupDouble-blindPrevention

Summary

This study is a randomized, placebo-controlled, double-blind, multicenter phase III clinical trial of Yiqi Wenjing prescriptions for Preventing Oxaliplatin-induced Peripheral Neuropathy.

Timeline

Start: 2021-01-01
Primary completion: 2022-07-01
Completion: 2022-10-01

Publications

Gu Z, Wei G, Zhu L, Zhu L, Hu J, Li Q, Cai G, Lu H, Liu M, Chen C, Ji Y, Li G, Huo J. Preventive Efficacy and Safety of Yiqi-Wenjing-Fang Granules on Oxaliplatin-Induced Peripheral Neuropathy: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Evid Based Complement Alternat Med. 2021 Sep 29;2021:5551568. doi: 10.1155/2021/5551568. eCollection 2021.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Danggui-Sini granules	Traditional medicine (herbal / TCM)	0.5 unknown	Oral
Subject	Huangqi-Guizhi-Wuwu granules	Traditional medicine (herbal / TCM)	0.5 unknown	Oral

Indications